Description/achievement of initiative
Gavi is an international organisation that was created in 2000 to improve access to new and underused vaccines for children living in the worlds poorest countries. Based in Geneva, Switzerland, Gavi is the Vaccine Alliance, which brings together public and private sectors with the shared goal of creating equal access to vaccines for children, wherever they live.
The 2016-20 strategy has four goals, each supporting our overall mission: to save childrens lives and protect peoples health by increasing equitable use of vaccines in lower-income countries:
The vaccine goal: accelerate equitable uptake and coverage of vaccines;
The systems goal: increase effectiveness and efficiency of immunisation delivery as an integrated part of strengthened health systems;
The sustainability goal: improve sustainability of national immunisation programmes;
The market shaping goal: shape markets for vaccines and other immunisation products.
The strategic framework includes eight principles, intended to define the Vaccine Alliances characteristics, its business model and its aspirations: country-led, community-owned, globally engaged, catalytic and sustainable, integrated, innovative, collaborative and accountable.
The framework also includes four strategic enablers. These are critical elements that the Vaccine Alliance, including countries, need to put in place to successfully achieve the four strategic goals.
The strategic enablers are: in-country leadership, management & coordination; advocacy; resource mobilisation and monitoring & evaluation.
Arrangements for Capacity-Building and Technology Transfer
Coordination mechanisms/governance structure
A unique public-private partnership, Gavi was created to bring together the best of what key UN agencies, governments, the vaccine industry, private sector and civil society had to offer in order to improve childhood immunisation coverage in poor countries and to accelerate access to new vaccines.
As a public-private partnership, Gavi represents the sum of its partners' individual strengths, from WHO's scientific expertise and UNICEF's procurement system to the financial know-how of the World Bank and the market knowledge of the vaccine industry.
WHO, UNICEF and World Bank